Upsher-Smith releases Anafranil generic

Print Friendly, PDF & Email

MAPLE GROVE, Minn — Upsher-Smith Laboratories Inc. has launched clomipramine hydrochloride capsules, an antidepressant, in the United States.

Upsher-Smith said its clomipramine hydrochloride comes in dosages of 25 mg, 50 mg and 75 mg in 100-count bottles and is a generic version of Anafranil capsules from Mallinckrodt Pharmaceuticals.

A tricyclic antidepressant, Anafranil is indicated for the treatment of obsessions and compulsions in patients with obsessive-compulsive disorder.

Clomipramine hydrochloride capsules totaled U.S. sales of approximately $172 million for the 12 months ended in December, according to IMS Health data reported by Upsher-Smith.

“Upsher-Smith currently has more active ANDA programs in development than at any point in its history and is committed to expanding its portfolio of quality, high-value generic products through both internal development and strategic partnerships,” stated Rusty Field, president of Upsher-Smith.



Comments are closed.